The Prognostic Value of the Albumin to Gamma-Glutamyltransferase Ratio in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation

Table 4

Comparison of predictive efficacy among different liver function-related indices.

	Training cohort				Validation cohort
	-index	AUC (95% CI)		LAT	-index	AUC (95% CI)		LAT
		3-year OS	5-year OS			3-year OS	5-year OS
AGR	0.64 (0.49-0.78)	0.63 (0.48-0.76)	0.65 (0.52-0.78)	11.2	0.62 (0.50-0.74)	0.59 (0.50-0.69)	0.63 (0.52-0.73)	6.7
ALBI grade	0.61 (0.48-0.76)	0.61 (0.46-0.76)	0.63 (0.50-0.77)	4.9	0.52 (0.42-0.64)	0.51 (0.41-0.61)	0.53 (0.43-0.64)	3.1
CP grade	0.52 (0.37-0.68)	0.52 (0.36-0.67)	0.53 (0.38-0.68)	2.2	0.50 (0.38-0.62)	0.49 (0.38-0.57)	0.52 (0.40-0.63)	0.7

Abbreviations: AUC: area under the curve; LAT ; likelihood ratio test ; OS: overall survival; AGR: albumin to gamma-glutamyltransferase ratio; ALBI grade: albumin-bilirubin grade; CP grade: Child-Pugh grade. Statistically significant.